CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: However, at seven days post-IM treatment, some deviation in gene expression from chronic phase CML was observed, suggesting early changes in gene expression occur in CD34+ cells from chronic phase CML following a seven-day IM therapy.